1Sullivan PS, Hanson DL, Chu SY, et al. Epidemiology of anemia in human immunodeficiency virus infected persons:results from the multistate adult and adolescent spectrum of HIV disease survdllance project[J]. Blood, 1998,91:301 - 308.
2Levine AM. Program and abstracts of the X III International AIDS Conference, July 9-14 2000 [ C ]. Durban South Africa: Abstract Mopeb 2 180.
3Moore RD, Keruly JC,Chaisson RE. Anemia and survival in HIV infection[J]. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 19:29 - 33.
4Moses AU,Williams S, Henevild ML,et al. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stroreal hematopoietic growth factors[ J ]. Blood, 1996,87: 919 - 925.
5Mocroft A,Kirk O,Barton SE,et al. Anaemia is an independent predictive marker for clinical prognosis in HIV infected patients from across Europe[ J ]. AIDS, 1999,13 : 943 - 950.
6Sipsas NV, Kokori SI, Ionnidis JPA, et al. Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1 related anemia[J ]. J Infect Dis, 1999,180:2 044 - 2 047.
7Senevirame LS, Tulpule A, Mummaneni M, et al. Clinical, immunological and pathologic correlates of bone marrow involvement in 253 patients with AIDS-related lymphoma[J]. Blood. 1998,92:244A.
8Jani AA., Bishai WR, Cohn SE, et al. Adherence to HIV treatment regimens: recommendations for best practices [ ED/OL ] . Available at: http://www. apha. org/ppp/hiv/Best _ Practices. pdf. Accessed August 2004.
9Descamps D, Flandre P, Calvez V, et al. Mechanisms of virologic failure in previously untreated HIV infected patients from a trial of induction-maintenance therapy. Trilege(Agence Nationale de Recherches sur le SIDA 072) Study Team[J] .JAMA,2000,283:205- 211.
10Montaner JS, Reiss P, Cooper D, et al. A randomized, double-bind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands,Canada and Australia Study[J ]. JAMA, 1998,279: 930 - 937.
